Literature DB >> 9103273

Bioavailability of the dietary antioxidant flavonol quercetin in man.

P C Hollman1, J M van Trijp, M J Mengelers, J H de Vries, M B Katan.   

Abstract

Quercetin, a dietary antioxidant flavonoid, has anticarcinogenic properties. We quantified the absorption of quercetin in ileostomists. Absorption was 52 +/- 5% for quercetin glucosides from onions, 17 +/- 15% for quercetin rutinoside, and 24 +/- 9% for quercetin aglycone. The plasma quercetin concentration in subjects with an intact colon, after ingestion of fried onions, apples and pure quercetin rutinoside, decreased slowly with elimination half-lives of about 25 h. Thus, repeated dietary intake of quercetin will lead to accumulation in plasma. The relative bioavailability of quercetin from apples and rutinoside was one-third of that from onions. Absorption kinetics and bioavailibility might be determined by the type of glycoside. Dietary quercetin could increase the antioxidant capacity of blood plasma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9103273     DOI: 10.1016/s0304-3835(97)04644-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  30 in total

1.  Quercetin blocks airway epithelial cell chemokine expression.

Authors:  Suparna Nanua; Suzanna M Zick; Juan E Andrade; Umadevi S Sajjan; John R Burgess; Nicholas W Lukacs; Marc B Hershenson
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

Review 2.  Dietary inhibitors of monoamine oxidase A.

Authors:  Sarah E Dixon Clarke; Rona R Ramsay
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

3.  Quercetin and omega 3 ameliorate oxidative stress induced by aluminium chloride in the brain.

Authors:  Haytham Abdallah Ali; Mohamed Afifi; Aaser Mohamed Abdelazim; Yahia Youssef Mosleh
Journal:  J Mol Neurosci       Date:  2014-02-01       Impact factor: 3.444

4.  Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.

Authors:  R Strick; P L Strissel; S Borgers; S L Smith; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

5.  Effect of quercetin glucosides from Allium extracts on HepG2, PC-3 and HT-29 cancer cell lines.

Authors:  Yingkun Pan; Yi Mei Zheng; Wing Shing Ho
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

6.  Bioavailability of phenolic antioxidants associated with dietary fiber: plasma antioxidant capacity after acute and long-term intake in humans.

Authors:  Jara Pérez-Jiménez; José Serrano; Maria Tabernero; Sara Arranz; M Elena Díaz-Rubio; Luis García-Diz; Isabel Goñi; Fulgencio Saura-Calixto
Journal:  Plant Foods Hum Nutr       Date:  2009-06       Impact factor: 3.921

7.  Effects of grape pomace on the antioxidant defense system in diet-induced hypercholesterolemic rabbits.

Authors:  Chang-Sook Choi; Hae-Kyung Chung; Mi-Kyung Choi; Myung-Hwa Kang
Journal:  Nutr Res Pract       Date:  2010-04-28       Impact factor: 1.926

8.  Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Sangbrita S Chattoraj; Asamanja Chattoraj; John R Burgess; Jeffrey L Curtis; Fernando J Martinez; Suzanna Zick; Marc B Hershenson; Uma S Sajjan
Journal:  Respir Res       Date:  2010-09-28

9.  Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib.

Authors:  Feng-Ting Liu; Samir G Agrawal; Zanyar Movasaghi; Peter B Wyatt; Ihtesham U Rehman; John G Gribben; Adrian C Newland; Li Jia
Journal:  Blood       Date:  2008-07-16       Impact factor: 22.113

10.  Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta.

Authors:  Zohara Sternberg; Kailash Chadha; Alicia Lieberman; Allison Drake; David Hojnacki; Bianca Weinstock-Guttman; Frederick Munschauer
Journal:  J Neuroinflammation       Date:  2009-10-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.